This report describes findings from two cases in which TB was misdiagnosed due to laboratory cross-contamination and summarizes the results of the ensuing investigation, which demonstrated the value of DNA fingerprinting to identify occurrences of cross-contamination among patient specimens.
Favorite
2000
This guideline presents updated data about drug interactions between protease inhibitors and non-nucleoside reverse transcriptase inhibitors for treatment of HIV infection together with rifamycins for treatment of TB.
Favorite
2000
This notice explains that on September 30, 1999, the Food and Drug Administration approved a reformulated amplified Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacterium tuberculosis in acid-fast Bacille (AFB) smear-positive and smear-negative respiratory specimens from patients suspected of having TB.
Favorite
Lab Personnel
2000
This report discusses the economic, psychological, and social impacts of TB and the strategies that households use to cope with them.
Favorite
International Agencies
2000
This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.
Favorite
International Agencies
2000
This report describes World TB Day events and activities that took place on March 24, 2000 to raise public awareness about the extent of the TB epidemic in various countries and territories around the world.
Favorite
Community Leaders
International Agencies
2000
This booklet explains the relationship between MDR-TB, DOTS, and DOTS-Plus and how projects can become a DOTS-Plus pilot project that can benefit from concessionary prices negotiated for second-line anti-TB drugs by the Working Group.
Favorite
Managers and Supervisors
2000
This brochure indicates that although TB affects people worldwide, it can be prevented, treated, and cured. The brochure also lists the symptoms of TB and those individuals who are at risk for TB.
Favorite
2000
This guideline is intended to provide a framework and understanding of the diagnostic approaches to TB infection/disease and to present a classification scheme that facilitates management of all persons who have had diagnostic tests.
Favorite
2000
This report presents the findings of a short-term study to examine the risk of TB among health care workers. It discusses the possible effects of federal guidelines, responses to resurgent TB, and proposed strategies for eliminating TB in the United States and worldwide.
Favorite
Health Educators/Communicators
Infection Control and Occupational Health Workers
2001
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
Favorite
2001
This report provides findings from a study designed to compare a whole-blood interferon gamma assay, the QuantiFERON-TB test, with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection and to identify factors associated with discordance between the tests.
Favorite
2001
This information packet discusses the use of a clinician-based referral and tracking system for migrant workers with TB. It includes samples of a pocket-sized bilingual (English/Spanish) treatment record for migrant workers.
Favorite
2001
This monograph discusses the history of TB, the search for TB treatment and diagnostic methods, and its resurgence, including the emergence of multiple drug resistant (MDR) strains of TB.
Favorite
2001
These four self-study modules cover public health and public nursing issues, the fundamentals of TB case management, leadership skills of the nurse case manager, and case management of pediatric patients with TB.
Favorite
2001
